GeneDx posts 41% revenue growth, issues 2026 guidance
Go back to GeneDx posts 41% revenue growth, issues 2026 guidance| (NASDAQ: WGS) | Delayed: 82.55 +2.90 (3.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.65 | 52 Week High | $ | |||
| Open | $79.29 | 52 Week Low | $ | |||
| Day High | $84.41 | P/E | N/A | |||
| Day Low | $78.80 | EPS | $ | |||
| Volume | 453,333 | |||||

